Difficulty: Medium
Average Score: 73%
Practice
Hepatic fibrosis that leads to portal hypertension is a usual finding in
Correct answer
D
Rationale
In this question, the correct answer is D) autosomal recessive polycystic kidney disease (ARPKD). Hepatic fibrosis leading to portal hypertension is a common complication of ARPKD due to the formation of cysts in the liver. ARPKD is a genetic disorder characterized by the development of cysts in the kidneys and liver, leading to progressive liver fibrosis, which can result in portal hypertension.
Option A) Poland syndrome is a condition characterized by abnormalities in the chest wall muscles, not associated with hepatic fibrosis or portal hypertension.
Option B) VACTERL association is a cluster of congenital anomalies involving vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula, renal anomalies, and limb abnormalities. While renal anomalies are part of the VACTERL association, hepatic fibrosis and portal hypertension are not typical features.
Option C) Multicystic renal dysplasia refers to the abnormal development of the kidney tissue, leading to the formation of multiple cysts in the kidney. This condition does not typically involve hepatic fibrosis or portal hypertension.
Educationally, understanding the manifestations of different pediatric GU disorders is crucial for healthcare providers working with pediatric patients. Recognizing the specific characteristics and complications of each disorder, such as ARPKD in this case, aids in accurate diagnosis, appropriate management, and improved patient outcomes. This question highlights the importance of linking pathophysiology with clinical manifestations in pediatric pharmacology education.
Option A) Poland syndrome is a condition characterized by abnormalities in the chest wall muscles, not associated with hepatic fibrosis or portal hypertension.
Option B) VACTERL association is a cluster of congenital anomalies involving vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula, renal anomalies, and limb abnormalities. While renal anomalies are part of the VACTERL association, hepatic fibrosis and portal hypertension are not typical features.
Option C) Multicystic renal dysplasia refers to the abnormal development of the kidney tissue, leading to the formation of multiple cysts in the kidney. This condition does not typically involve hepatic fibrosis or portal hypertension.
Educationally, understanding the manifestations of different pediatric GU disorders is crucial for healthcare providers working with pediatric patients. Recognizing the specific characteristics and complications of each disorder, such as ARPKD in this case, aids in accurate diagnosis, appropriate management, and improved patient outcomes. This question highlights the importance of linking pathophysiology with clinical manifestations in pediatric pharmacology education.